US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
CN1370176A
(zh)
*
|
1999-06-15 |
2002-09-18 |
布里斯托尔-迈尔斯斯奎布药品公司 |
取代的杂环稠合γ-咔啉
|
AR035493A1
(es)
*
|
2000-09-20 |
2004-06-02 |
Upjohn Co |
Derivados de azepino (4,5b) indolina sustituidos, composicion farmaceutica y el uso de dichos derivados para preparar un medicamento
|
US6777407B2
(en)
|
2000-11-03 |
2004-08-17 |
Wyeth |
Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
AR031199A1
(es)
|
2000-11-03 |
2003-09-10 |
Wyeth Corp |
Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados
|
AR031200A1
(es)
|
2000-11-03 |
2003-09-10 |
Wyeth Corp |
Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados
|
DE60139021D1
(de)
|
2000-11-20 |
2009-07-30 |
Biovitrum Ab Publ |
Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors
|
SE0004245D0
(sv)
|
2000-11-20 |
2000-11-20 |
Pharmacia Ab |
Novel compounds and their use
|
RU2003121304A
(ru)
*
|
2000-12-20 |
2005-01-27 |
Бристол-Маерс Сквибб Компани (Us) |
Замещенные пиридоиндолы в качестве агонистов и антагонистов серотонина
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
CA2447156A1
(en)
*
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Novel fused indazoles and indoles and their use for the treatment of glaucoma
|
CN1512879A
(zh)
*
|
2001-06-01 |
2004-07-14 |
�Ƹ��� |
新的芳氨基丙烷类似物及其用于治疗青光眼的用途
|
CA2447480A1
(en)
*
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Pyranoindazoles and their use for the treatment of glaucoma
|
US20030060462A1
(en)
*
|
2001-08-06 |
2003-03-27 |
Hoffman Robert L. |
Therapeutic compounds
|
MXPA04001202A
(es)
|
2001-08-06 |
2005-02-17 |
Pharmacia & Upjhon Company |
Ligandos tetraciclicos terapeuticamente utiles.
|
AU2002336749A1
(en)
|
2001-09-21 |
2003-04-01 |
Pharmacia And Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
WO2003033497A1
(en)
*
|
2001-10-18 |
2003-04-24 |
Pharmacia & Upjohn Company |
Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity
|
TW200307540A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
[1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
|
TWI312781B
(en)
|
2002-04-25 |
2009-08-01 |
|
[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
TW200307682A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
AU2003243089B2
(en)
|
2002-06-19 |
2010-01-07 |
Biovitrum Ab (Publ) |
Novel compounds, their use and preparation
|
US6958420B2
(en)
*
|
2002-07-19 |
2005-10-25 |
Board Of Trustees Of Michigan State University |
Synthesis of aminoarylboronic esters and substituted anilines from arenes via catalytic C-H activation/borylation/amination and uses thereof
|
PL375564A1
(en)
*
|
2002-08-30 |
2005-11-28 |
Alcon, Inc. |
Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
|
WO2004054572A2
(en)
|
2002-12-13 |
2004-07-01 |
Alcon, Inc. |
Novel benzopyran analogs and their use for the treatment of glaucoma
|
ATE509929T1
(de)
*
|
2002-12-19 |
2011-06-15 |
Bristol Myers Squibb Co |
Substituierte tricyclische gamma-carbolineals serotonin-rezeptor-agonisten und antagonisten
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
US7728155B2
(en)
|
2003-10-24 |
2010-06-01 |
Wyeth Llc |
Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
|
US7476687B2
(en)
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
WO2005058911A2
(en)
|
2003-12-15 |
2005-06-30 |
Alcon, Inc. |
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
|
ZA200608176B
(en)
|
2004-03-15 |
2008-05-28 |
Ptc Therapeutics Inc |
Carboline derivatives useful in the inhibition of angiogenesis
|
US7767689B2
(en)
*
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
MXPA06014565A
(es)
|
2004-06-18 |
2007-03-23 |
Wyeth Corp |
Procesos para preparar 6-alquil-5-arilsulfonil-dihidrofenantridinas.
|
EP2248524A3
(de)
|
2004-08-25 |
2011-03-09 |
Takeda Pharmaceutical Company Limited |
Mittel zur prävention/behandlung von stressbedingter harninkontinenz und vorsorgeuntersuchungsverfahren dafür
|
GT200500317A
(es)
|
2004-11-05 |
2006-10-27 |
|
Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
|
WO2006062839A1
(en)
|
2004-12-08 |
2006-06-15 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
AR054849A1
(es)
|
2005-07-26 |
2007-07-18 |
Wyeth Corp |
Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
|
WO2007084622A2
(en)
*
|
2006-01-19 |
2007-07-26 |
Athersys, Inc. |
Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof
|
JP5528699B2
(ja)
|
2006-05-16 |
2014-06-25 |
武田薬品工業株式会社 |
縮合複素環化合物およびその用途
|
JP2010500300A
(ja)
|
2006-08-08 |
2010-01-07 |
サノフィ−アベンティス |
アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
|
WO2008112280A1
(en)
|
2007-03-12 |
2008-09-18 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
US20100120694A1
(en)
|
2008-06-04 |
2010-05-13 |
Synergy Pharmaceuticals, Inc. |
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
|
EP2527360B1
(de)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
EP2789338A3
(de)
|
2007-11-15 |
2015-01-14 |
Takeda Pharmaceutical Company Limited |
Kondensiertes Pyridinderivat und seine Verwendung
|
ES2523580T3
(es)
*
|
2008-01-11 |
2014-11-27 |
Albany Molecular Research, Inc. |
Piridoindoles substituidos con (1-Azinona)
|
CN105237536A
(zh)
*
|
2008-03-12 |
2016-01-13 |
细胞内治疗公司 |
取代的杂环稠合的γ-咔啉固体
|
AU2015218433B2
(en)
*
|
2008-05-27 |
2017-07-27 |
Intra-Cellular Therapies, Inc. |
Methods and compositions for sleep disorders and other disorders
|
EP2320731A4
(de)
|
2008-05-27 |
2012-09-26 |
Intra Cellular Therapies Inc |
Verfahren und zusammensetzungen für schlafstörungen und sonstige störungen
|
EP2310372B1
(de)
|
2008-07-09 |
2012-05-23 |
Sanofi |
Heterocyclische Verbindungen, Verfahren zu ihrer Herstellung, Arzneimitteln mit diesen Verbindungen und ihre Verwendung
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
CN102227431A
(zh)
*
|
2008-09-29 |
2011-10-26 |
雅培制药有限公司 |
吲哚和二氢吲哚衍生物及其应用方法
|
US9625475B2
(en)
*
|
2008-09-29 |
2017-04-18 |
Abbvie Inc. |
Indole and indoline derivatives and methods of use thereof
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
EP2448585B1
(de)
*
|
2009-07-01 |
2014-01-01 |
Albany Molecular Research, Inc. |
Azinon-substituiertes azepin[b]indol und pyrido-pyrrolo-azepin mch-1 antagonisten, verfahren zur herstellung und verwendung davon
|
WO2011003007A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
|
WO2011003012A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
|
WO2011003021A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
|
WO2011008572A2
(en)
|
2009-07-14 |
2011-01-20 |
Albany Molecular Research, Inc. |
5-ht3 receptor modulators, methods of making, and use thereof
|
US8785608B2
(en)
|
2009-08-26 |
2014-07-22 |
Sanofi |
Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
WO2011044134A1
(en)
|
2009-10-05 |
2011-04-14 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
|
EP2510949A4
(de)
|
2009-12-11 |
2013-11-13 |
Astellas Pharma Inc |
Therapeutikum für fibromyalgie
|
US9034865B2
(en)
|
2010-02-18 |
2015-05-19 |
Medivation Technologies, Inc. |
Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
WO2011103485A1
(en)
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
|
WO2011103460A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]ondole derivatives and methods of use
|
ES2602503T3
(es)
|
2010-04-22 |
2017-02-21 |
Intra-Cellular Therapies, Inc. |
Compuestos orgánicos
|
US20130267500A1
(en)
|
2010-09-01 |
2013-10-10 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
WO2012088124A2
(en)
|
2010-12-21 |
2012-06-28 |
Albany Molecular Research, Inc. |
Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
|
WO2012088038A2
(en)
|
2010-12-21 |
2012-06-28 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
|
US9067949B2
(en)
|
2011-01-19 |
2015-06-30 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
US9434747B2
(en)
|
2011-02-18 |
2016-09-06 |
Medivation Technologies, Inc. |
Methods of treating diabetes
|
AU2012223337C1
(en)
|
2011-03-01 |
2016-11-10 |
Bausch Health Ireland Limited |
Process of preparing guanylate cyclase C agonists
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
WO2012120051A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683700B1
(de)
|
2011-03-08 |
2015-02-18 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
WO2012120057A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
WO2012120050A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
EP2683701B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
EP2567959B1
(de)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
|
IN2014DN08562A
(de)
|
2012-04-14 |
2015-05-22 |
Intra Cellular Therapies Inc |
|
EP3610890A1
(de)
|
2012-11-14 |
2020-02-19 |
The Johns Hopkins University |
Verfahren und zusammensetzungen zur behandlung von schizophrenie
|
US9822117B2
(en)
*
|
2013-03-04 |
2017-11-21 |
Daya Drug Discoveries, Inc. |
Pyridoindolobenz[b,d]azepine derivatives and uses thereof
|
PT2968320T
(pt)
|
2013-03-15 |
2021-01-28 |
Intra Cellular Therapies Inc |
Compostos orgânicos
|
WO2014151206A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
US10011637B2
(en)
|
2013-06-05 |
2018-07-03 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase C, method of making and using same
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
PL3076967T3
(pl)
*
|
2013-12-03 |
2021-12-20 |
Intra-Cellular Therapies, Inc. |
Metody leczenia objawów rezydualnych schizofrenii
|
BR112016023162B1
(pt)
|
2014-04-04 |
2022-11-29 |
Intra-Cellular Therapies, Inc |
Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central
|
US9745300B2
(en)
|
2014-04-04 |
2017-08-29 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2016172496A1
(en)
|
2015-04-23 |
2016-10-27 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
MX2018009158A
(es)
|
2016-01-26 |
2018-11-19 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
PL3407889T3
(pl)
|
2016-03-25 |
2021-11-22 |
Intra-Cellular Therapies, Inc. |
Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego
|
WO2017172795A1
(en)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
US10654854B2
(en)
|
2016-03-28 |
2020-05-19 |
Intra-Cellular Therapies, Inc. |
Salts and crystals of ITI-007
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
EP3525763A4
(de)
|
2016-10-12 |
2020-06-17 |
Intra-Cellular Therapies, Inc. |
Amorphe feste dispersionen
|
EP3532459B1
(de)
|
2016-10-26 |
2023-08-02 |
Constellation Pharmaceuticals, Inc. |
Lsd1-inhibitoren und medizinische verwendungen davon
|
WO2018106916A1
(en)
*
|
2016-12-07 |
2018-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated quinoxaline compounds
|
JP6987868B2
(ja)
*
|
2016-12-29 |
2022-01-05 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
有機化合物
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
CN116327770A
(zh)
|
2017-03-24 |
2023-06-27 |
细胞内治疗公司 |
新组合物和方法
|
JP2020513023A
(ja)
|
2017-04-10 |
2020-04-30 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
ルマテペロンp−トシラートの非晶質形態および固体分散体
|
CN111093665A
(zh)
*
|
2017-07-26 |
2020-05-01 |
细胞内治疗公司 |
有机化合物
|
US11427587B2
(en)
|
2017-07-26 |
2022-08-30 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US10513515B2
(en)
|
2017-08-25 |
2019-12-24 |
Biotheryx, Inc. |
Ether compounds and uses thereof
|
US11440911B2
(en)
|
2017-09-26 |
2022-09-13 |
Intra-Cellular Therapies, Inc. |
Salts and crystals
|
WO2019102240A1
(en)
*
|
2017-11-27 |
2019-05-31 |
Egis Gyógyszergyár Zrt. |
Method for the manufacture of lumateperone and its salts
|
JPWO2019131902A1
(ja)
|
2017-12-27 |
2020-12-10 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|
WO2019178484A1
(en)
|
2018-03-16 |
2019-09-19 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
CA3094949A1
(en)
|
2018-03-23 |
2019-09-26 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocycle fused gamma-carbolines
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
BR112021001738A2
(pt)
|
2018-06-21 |
2021-06-29 |
Aquestive Therapeutics, Inc. |
sistema e método para fabricação de doses unitárias individuais personalizadas contendo ativos farmacêuticos
|
CN109100437A
(zh)
*
|
2018-07-22 |
2018-12-28 |
邯郸学院 |
仲胺类抗抑郁药物的质谱检测方法
|
EP3830093A1
(de)
|
2018-07-27 |
2021-06-09 |
Biotheryx, Inc. |
Bifunktionelle verbindungen als cdk-modulatoren
|
BR112021003655A2
(pt)
|
2018-08-31 |
2021-05-18 |
Intra-Cellular Therapies, Inc. |
métodos novos
|
EP3843739A4
(de)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
Neuartige verfahren
|
CA3110997A1
(en)
|
2018-09-07 |
2020-03-12 |
Aquestive Therapeutics, Inc. |
Oral film compositions and dosage forms having precise active dissolution profiles
|
WO2020112941A2
(en)
|
2018-11-27 |
2020-06-04 |
Teva Czech Industries S.R.O |
Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof
|
KR20210104833A
(ko)
*
|
2018-12-17 |
2021-08-25 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로사이클 융합 감마-카르볼린 합성
|
MX2021007217A
(es)
*
|
2018-12-17 |
2021-07-15 |
Intra Cellular Therapies Inc |
Compuesto organico.
|
EP3898581A4
(de)
*
|
2018-12-17 |
2022-08-17 |
Intra-Cellular Therapies, Inc. |
Synthese kondensierter gamma-carboline mit substituiertem heterozyklus
|
US20220056031A1
(en)
|
2018-12-21 |
2022-02-24 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
EP3914235A4
(de)
*
|
2019-01-23 |
2022-09-07 |
Intra-Cellular Therapies, Inc. |
Verfahren zur behandlung von sucht
|
MX2021010193A
(es)
|
2019-02-27 |
2021-09-21 |
Univ California |
Azepino-indoles y otros heterociclos para el tratamiento de trastornos cerebrales.
|
WO2020206391A1
(en)
*
|
2019-04-04 |
2020-10-08 |
Intra-Cellular Therapies, Inc. |
Methods of treating neuropathic pain
|
EP4134101A1
(de)
|
2019-07-07 |
2023-02-15 |
Intra-Cellular Therapies, Inc. |
Deuteriertes lumateperon zur behandlung der bipolar-ii-störung
|
EP4051235A1
(de)
|
2019-11-01 |
2022-09-07 |
Aquestive Therapeutics, Inc. |
Prodrug-zusammensetzungen und verfahren zur behandlung
|
EP4058029A1
(de)
|
2019-11-14 |
2022-09-21 |
Aquestive Therapeutics, Inc. |
Multimodale zusammensetzungen und verfahren zur behandlung
|
WO2021119334A1
(en)
|
2019-12-11 |
2021-06-17 |
Intra-Cellular Therapies, Inc. |
Organic compound
|
US11897930B2
(en)
|
2020-04-28 |
2024-02-13 |
Anwita Biosciences, Inc. |
Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
|
CA3194682A1
(en)
*
|
2020-10-09 |
2022-04-14 |
Zehong Wan |
Heterocyclic substituted fused .gamma.-carboline derivative, preparationmethod therefor, intermediate thereof and use thereof
|
CN112062767B
(zh)
*
|
2020-10-20 |
2022-03-11 |
杭州科巢生物科技有限公司 |
一种卢美哌隆的制备方法及其中间体
|
KR20230134136A
(ko)
|
2021-01-15 |
2023-09-20 |
어퀘스티브 테라퓨틱스, 아이엔씨. |
전구약물 조성물 및 치료 방법
|
US20220347117A1
(en)
|
2021-03-09 |
2022-11-03 |
Aquestive Therapeutics, Inc. |
Dosage forms having equivalent biocomparable profiles
|
CN116444520A
(zh)
*
|
2022-01-14 |
2023-07-18 |
上海科技大学 |
并环哌啶类化合物及其制备方法和用途
|
CN114456149A
(zh)
*
|
2022-02-24 |
2022-05-10 |
中国科学技术大学 |
一种多巴胺drd2受体拮抗剂及其用途
|
WO2023178111A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2023178113A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2023225620A1
(en)
|
2022-05-18 |
2023-11-23 |
Intra-Cellular Therapies, Inc. |
Novel methods
|